The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of pelareorep in activating anti-tumor immunity in PDAC.
 
Richard Trauger
No Relationships to Disclose
 
Richard Vile
No Relationships to Disclose
 
Jens Siveke
Stock and Other Ownership Interests - FAPi Holding AG
Consulting or Advisory Role - AstraZeneca; AstraZeneca (Inst); Bayer; Bristol-Myers Squibb/Celgene; Falk Foundation; Immunocore; MCI Deutschland; MSD; MSD; Novartis; Roche; SERVIER
Research Funding - Abalos Therapeutics (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Eisbach Bio (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - SERVIER
 
Sven-Thorsten Liffers
No Relationships to Disclose
 
Thomas Heineman
Employment - Oncolytics
Leadership - Oncolytics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Halozyme; Johnson & Johnson/Janssen; Merck; Oncolytics; Pfizer; Takeda
Patents, Royalties, Other Intellectual Property - Halozyme: PCT/US19/32537 Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble PH20 Genocea: PCT/US 62/855,309; PCT/US 62/848,527 Methods of identifying and/or selecting antigens that improve, increase and/or s
Travel, Accommodations, Expenses - Oncolytics
 
Matt Coffey
No Relationships to Disclose